Epiduo Forte Gel Approved for Treating Acne
July 15, 2015 - The U.S. Food and Drug Administration approved a new strength of Epiduo (adapalene/benzoyl peroxide) 0.1%/2.5% gel, manufactured by Galderma Laboratories.
Epiduo Forte (adapalene/benzoyl peroxide) gel 0.3%/2.5% was approved for treating acne. This is a combination of Adapalene, which is a retinoid that helps to control both inflammation and pimple formation, and benzoyl peroxide, which is an antibacterial that also dries skin and lessens oil production. Epiduo Forte is to be applied once daily to acne affected areas, but must not be used on eyes or lips. When using Epiduo Forte, patients are advised to use sunscreen on treated areas exposed to sunlight as they can become more sensitive to natural or artificial sunlight.
Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval. Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval. Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability. All trademarks are the property of their respective owners.
*This is provided for information only. The reference to any medication above does not mean the medication is covered by your plan.